CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — fact timeline

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. issued 2,790,340 shares of common stock of warrant to holders of existing warrants for cash exercise of existing warrants at $3.75 per share for aggregate gross proceeds of approximately $4.2 million.

“On October 29, 2025, Creative Medical Technology Holdings, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with the holders (the “Holders”) of warrants to purchase an aggregate of 1,116,136 shares of the Company’s common stock originally issued on March 6, 2025 (collectively, the “Existing Warrants”), pursuant to which the Holders agreed to exercise the Existing Warrants at their current exercise price of $3.75 per share, in exchange for the Company’s agreement to issue the Holders new warrants to purchase an aggregate of 2,790,340 shares of common stock (the “Inducement Warrants”).”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding other (rules 5608(b)(1), 5608(b)(2)).

“April 8, 2025, the Company received a letter from Nasdaq stating that because the Company failed to timely adopt the Policy as required by Listing Rule 5608(b)(1), and failed to disclose the Policy in its Form 10-K for the fiscal years ended December 31, 2023 or December 31, 2024 (prior to its amendment), the Company previously did not comply with Listing Rule 5608(b)(2). However, in the letter, Nasdaq further informed the Company that it is currently in compliance with Nasdaq Listing Rules, and the matter raised by Nasdaq in the letter is now closed.”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: Increased authorized common shares from 5,000,000 to 25,000,000 (effective 2024-12-19).

“On December 19, 2024, the stockholders of Creative Medical Technology Holdings, Inc. (the “Company”) approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of common stock from 5,000,000 to 25,000,000.”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Ratification of the appointment of Haynie & Company to serve as the Company's independent registered public accountants at the 2023-12-20 meeting.

“For Against Abstain Broker Non-Votes 751,848 23,485 1,649 N/A”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Approval of the compensation of the Company's named executive officers at the 2023-12-20 meeting.

“For Against Abstain Broker Non-Votes 169,498 90,645 1,077 515,762”

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Election of five director nominees to the Board at the 2023-12-20 meeting.

“Timothy Warbington 237,163 24,057 Donald Dickerson 237,192 24,028 Michael H. Finger 234,462 26,758 Susan Snow 237,729 23,491 Bruce S. Urdang, Esq. 235,547 25,673”